Contrast Media

Behind every image is a patient. We provide a comprehensive portfolio of contrast media to help meet patient and procedural needs across imaging modalities.
Support

Adverse events reporting

Adverse events should be reported
Reporting forms and information can be found at: http://www.mhra.gov.uk/yellowcard
Adverse events should also be reported to GE HealthCare at:
gpv.drugsafety@gehealthcare.com

110m+

doses currently produced globally every year1

30m

more iodinated contrast media doses to be delivered annually by 20251

4 cGMP

accredited contrast media production facilities globally

$385m

invested over the last decade to increase capacity1

CONTRAST MEDIA

GE HealthCare has a distinguished heritage of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.

Products

Omnipaque

Visipaque

Clariscan

Please click here for OMNIPAQUE™ (iohexol) Prescribing Information.
Please click here for VISIPAQUE™ (iodixanol) Prescribing Information.
Please click here for Clariscan™ (gadoteric acid) Prescribing Information.
Please click here for Rapiscan™ (regadenoson) Prescribing Information.
INNOVATIVE PACKAGING

+PLUSPAK 100% recyclable packaging

Our +PLUSPAK packaging, used for contrast media product, is 100% recyclable. A life-cycle analysis showed that our polypropylene bottles, compared to glass, have a 59% lower environmental impact, and requires 45% less cumulative energy. Our +PLUSPAK bottles, also require less secondary packaging, helping reduce carbon footprint.3
References
1. GE Healthcare Data on File: Planned Investment 2023
2. Dhaliwal et al. Int J Life Cycle Assess 2014; 19: 1965-73.

cGMP: Current Good Manufacturing Practice

JB03106UK